Cleveland BioLabs (CBLI) Receives Additional $1.5 Million in Funding for Development of CBLB502
Tweet Send to a Friend
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it received ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
